GTP cyclohydrolase 1 mutations and Parkinson's disease: New insights beyond DOPA‐responsive dystonia

Publisher： John Wiley & Sons Inc

E-ISSN： 1531-8257|30|7|910-910

ISSN： 0885-3185

Source： MOVEMENT DISORDERS, Vol.30, Iss.7, 2015-06, pp. : 910-910

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Premotor–motor excitability is altered in dopa‐responsive dystonia

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 12, 2015-10 ,pp. : 1705-1709

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evidence of a role for GTP cyclohydrolase‐1 in visceral pain

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 5, 2015-05 ,pp. : 656-662

John Wiley & Sons Inc

Access to resources Recommend Favorite

L‐Dopa Treatment of Parkinson's Disease

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 30, Iss. 5, 1982-05 ,pp. : 322-325

John Wiley & Sons Inc

Access to resources Recommend Favorite

Validating the GTP‐cyclohydrolase 1‐feedback regulatory complex as a therapeutic target using biophysical and in vivo approaches

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 16, 2015-08 ,pp. : 4146-4157

John Wiley & Sons Inc

Access to resources Recommend Favorite

Analysis of an early‐onset Parkinson's disease cohort for DJ‐1 mutations

By  

MOVEMENT DISORDERS, Vol. 19, Iss. 7, 2004-07 ,pp. : 796-800

John Wiley & Sons Inc

Access to resources Recommend Favorite